IX BIOPHARMA LTD.

Insiders iX Biopharma Ltd.

Equities

42C

SG1BD9000009

Delayed Singapore S.E. Other stock markets 22:45:42 2024-06-25 EDT			5-day change	1st Jan Change
0.031 ^SGD	+3.33%		-3.12%	-31.11%

06-19	Ix Biopharma Cuts Conversion Price of 9% Convertible Bonds	MT
06-11	Singapore Shares Fall As Federal Interest Rate Cut Hopes Dim; China Mining Up 29%	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Singapore Shares Fall As Federal Interest Rate Cut Hopes Dim; China Mining Up 29%	06-11	MT
IX Biopharma Ltd. Announces Board and Committee Appointment	22-11-07	CI
IX Biopharma Ltd. Announces Retirement of Mr. Low Weng Keong as Independent and Non-Executive Director	22-09-22	CI
IX Biopharma Ltd. Announces Cessation of Yee Chia Hsing as Director of Corporate Affairs & General Manager of Entity Health Ltd	22-07-15	CI
Actinogen Medical Names New Chief Medical Officer; Shares Rise 4%	22-02-14	MT
IX Biopharma Ltd. Announces Executive Changes	22-02-04	CI
IX Biopharma Ltd Appoints Angeline Tham as Non-Executive Independent Director, Member of Audit Committee and Remuneration Committee and Chairperson of Nominating Committee, Effective 1 February 2022	22-01-28	CI
IX Biopharma Ltd. Announces Management Appointments	21-10-27	CI
IX Biopharma Ltd. Announces Retirement of Claudia Teo Kwee Yee as a Director	21-09-28	CI
IX Biopharma Ltd. Appoints Yee Chia Hsing as Director of Corporate Affairs	21-02-28	CI
IX Biopharma Ltd. Appoints Ms. Eva Tan as Its New Chief Commercial Officer	21-01-18	CI
IX Biopharma Ltd. Announces the Appointment of Mr. Patrick Donald Davies as Non-Executive Independent Director, Effective from December 2, 2019	19-11-27	CI
IX Biopharma Ltd. Announces Appointment of Dr. Janakan Krishnarajah as Chief Operating Officer	19-03-29	CI
IX Biopharma Ltd. Announces Changes in the Composition of the Board and Remuneration Committee	18-11-12	CI
IX Biopharma Ltd. Announces Retirement of Ko Kheng Hwa as Lead Independent Director	18-10-19	CI
Ko Kheng Hwa Not Seek Reelection as Director of Ix Biopharma Ltd	18-09-26	CI
IX Biopharma Ltd. Announces Establishment of Risk Management Committee and Executive Appointments	17-11-07	CI
Ix Biopharma Ltd. Announces Appointment of Lam Li Fong as General Manager	15-09-25	CI
Ix Biopharma Ltd. Announces Appointment of Iain Bruce Cook as Chief Scientist	15-09-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer